Havn Life Sciences Stock Performance
| HAVLF Stock | USD 0.0001 0.00 0.00% |
HAVN Life holds a performance score of 7 on a scale of zero to a hundred. The firm retains a Market Volatility (i.e., Beta) of -74.13, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning HAVN Life are expected to decrease by larger amounts. On the other hand, during market turmoil, HAVN Life is expected to outperform it. Use HAVN Life Sciences standard deviation, as well as the relationship between the maximum drawdown and day median price , to analyze future returns on HAVN Life Sciences.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in HAVN Life Sciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain essential indicators, HAVN Life reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 9.4 M | |
| Total Cashflows From Investing Activities | -2 M | |
| Free Cash Flow | -8 M |
HAVN |
HAVN Life Relative Risk vs. Return Landscape
If you would invest 0.19 in HAVN Life Sciences on November 21, 2025 and sell it today you would lose (0.18) from holding HAVN Life Sciences or give up 94.74% of portfolio value over 90 days. HAVN Life Sciences is currently producing 12.3469% returns and takes up 130.9577% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than HAVN, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
HAVN Life Target Price Odds to finish over Current Price
The tendency of HAVN Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0001 | 90 days | 0.0001 | about 74.82 |
Based on a normal probability distribution, the odds of HAVN Life to move above the current price in 90 days from now is about 74.82 (This HAVN Life Sciences probability density function shows the probability of HAVN Pink Sheet to fall within a particular range of prices over 90 days) .
HAVN Life Price Density |
| Price |
Predictive Modules for HAVN Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as HAVN Life Sciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.HAVN Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. HAVN Life is not an exception. The market had few large corrections towards the HAVN Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold HAVN Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of HAVN Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 27.76 | |
β | Beta against Dow Jones | -74.13 | |
σ | Overall volatility | 0.0008 | |
Ir | Information ratio | 0.11 |
HAVN Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of HAVN Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for HAVN Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| HAVN Life Sciences is way too risky over 90 days horizon | |
| HAVN Life Sciences has some characteristics of a very speculative penny stock | |
| HAVN Life Sciences appears to be risky and price may revert if volatility continues | |
| HAVN Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| HAVN Life Sciences has accumulated 561.84 K in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. HAVN Life Sciences has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist HAVN Life until it has trouble settling it off, either with new capital or with free cash flow. So, HAVN Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HAVN Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HAVN to invest in growth at high rates of return. When we think about HAVN Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 276.47 K. Net Loss for the year was (22.44 M) with profit before overhead, payroll, taxes, and interest of 89.69 K. | |
| HAVN Life Sciences has accumulated about 112.42 K in cash with (7.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
HAVN Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of HAVN Pink Sheet often depends not only on the future outlook of the current and potential HAVN Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. HAVN Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.1 M | |
| Shares Float | 7.9 M |
HAVN Life Fundamentals Growth
HAVN Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of HAVN Life, and HAVN Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HAVN Pink Sheet performance.
| Return On Equity | -2.39 | |||
| Return On Asset | -0.37 | |||
| Operating Margin | (7.64) % | |||
| Current Valuation | 626.96 K | |||
| Shares Outstanding | 8.47 M | |||
| Price To Book | 0.21 X | |||
| Price To Sales | 0.98 X | |||
| Revenue | 276.47 K | |||
| EBITDA | (21.8 M) | |||
| Cash And Equivalents | 112.42 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 561.84 K | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (7.88 M) | |||
| Earnings Per Share | (0.15) X | |||
| Total Asset | 4.06 M | |||
About HAVN Life Performance
By analyzing HAVN Life's fundamental ratios, stakeholders can gain valuable insights into HAVN Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if HAVN Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if HAVN Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The company was incorporated in 2020 and is headquartered in Richmond, Canada. Havn Life operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about HAVN Life Sciences performance evaluation
Checking the ongoing alerts about HAVN Life for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for HAVN Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| HAVN Life Sciences is way too risky over 90 days horizon | |
| HAVN Life Sciences has some characteristics of a very speculative penny stock | |
| HAVN Life Sciences appears to be risky and price may revert if volatility continues | |
| HAVN Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| HAVN Life Sciences has accumulated 561.84 K in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. HAVN Life Sciences has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist HAVN Life until it has trouble settling it off, either with new capital or with free cash flow. So, HAVN Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HAVN Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HAVN to invest in growth at high rates of return. When we think about HAVN Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 276.47 K. Net Loss for the year was (22.44 M) with profit before overhead, payroll, taxes, and interest of 89.69 K. | |
| HAVN Life Sciences has accumulated about 112.42 K in cash with (7.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing HAVN Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HAVN Life's stock is overvalued or undervalued compared to its peers.
- Examining HAVN Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HAVN Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HAVN Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HAVN Life's pink sheet. These opinions can provide insight into HAVN Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for HAVN Pink Sheet analysis
When running HAVN Life's price analysis, check to measure HAVN Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HAVN Life is operating at the current time. Most of HAVN Life's value examination focuses on studying past and present price action to predict the probability of HAVN Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HAVN Life's price. Additionally, you may evaluate how the addition of HAVN Life to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |